Strabismus Completed Phase 3 Trials for Botulinum toxin type A (DB00083)

Also known as: Squint / Strabismus NOS / Heterophoria / Binocular eye movement disorder NOS / Heterotropia / Heterophoria, unspecified / Binocular eye movement disorder / Heterotropia, unspecified / Unspecified disorder of binocular eye movements

IndicationStatusPhase
DBCOND0009706 (Strabismus)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01584843Efficacy and Safety of GSK1358820 (Botulinum Toxin Type A) in Patients With StrabismusTreatment